Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Price to Book (2012 - 2026)

Analysis

Verastem (VSTM) Price to Book (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.91
Mar 31, 2026 5.69
Dec 31, 2025 10.49
Sep 30, 2025 -37.96
Jun 30, 2025 7.08
Mar 31, 2025 -9.57
Dec 31, 2024 -6.39
Sep 30, 2024 10.88
Jun 30, 2024 4.25
Mar 31, 2024 11.92
Dec 31, 2023 3.59
Sep 30, 2023 2.47
Jun 30, 2023 1.30
Mar 31, 2023 2.55
Dec 31, 2022 1.69
Sep 30, 2022 2.84
Jun 30, 2022 4.04
Mar 31, 2022 3.61
Dec 31, 2021 4.34
Sep 30, 2021 5.86